R. van Dalen
- Epidemiology
- Immunology
- Pharmacology top 10%
- Microbiology top 5%
- Molecular Medicine top 5%
- Co-authors
- T. B. VreeRobert W. SauerweinJohanna van der Ven‐JongekrijgA. K. M. BartelinkMarcel van DeurenJ.W.M. van der MeerH. GallatiJ W van der Meer
- Topics
- Antibiotics Pharmacokinetics and Efficacy (5 papers)Antibiotic Resistance in Bacteria (3 papers)Pneumonia and Respiratory Infections (2 papers)
- Journals
- The Journal of Infectious DiseasesIntensive Care MedicineJournal of Antimicrobial Chemotherapy
- Partner nations
- NetherlandsNew ZealandAustralia
In The Last Decade
R. van Dalen
15 papers receiving 566 citations
Peers
Comparison fields: 5 of 86
- Epidemiology 207
- Immunology 189
- Pharmacology 140
- Microbiology 118
- Molecular Medicine 84
Countries citing papers authored by R. van Dalen
This map shows the geographic impact of R. van Dalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. van Dalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. van Dalen more than expected).
Fields of papers citing papers by R. van Dalen
This network shows the impact of papers produced by R. van Dalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. van Dalen. The network helps show where R. van Dalen may publish in the future.
Co-authorship network of co-authors of R. van Dalen
This figure shows the co-authorship network connecting the top 25 collaborators of R. van Dalen. A scholar is included among the top collaborators of R. van Dalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. van Dalen. R. van Dalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 49 | |
| 3 | Disposition kinetics of a severe overdose of carbamazepine. | 1 |
| 4 | 186 | |
| 5 | 134 | |
| 6 | 26 | |
| 7 | 73 | |
| 8 | 25 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 34 | |
| 12 | 6 | |
| 13 | 15 | |
| 14 | 15 | |
| 15 | 20 |
About R. van Dalen
R. van Dalen is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Emergency Medicine, having authored 15 papers that have together received 593 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (3 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Microbiology (118 citations), Molecular Medicine (84 citations) and Applied Microbiology and Biotechnology (32 citations). R. van Dalen has collaborated with scholars based in Netherlands, New Zealand and Australia. Frequent co-authors include T. B. Vree, Robert W. Sauerwein, Johanna van der Ven‐Jongekrijg, A. K. M. Bartelink, Marcel van Deuren, J.W.M. van der Meer, H. Gallati, J W van der Meer, J L Vannice and Pierre N.M. Demacker. Their work appears in journals such as The Journal of Infectious Diseases, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.